25
total announcements
BROOKS.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹203 Cr
P/E (TTM)
15.3
EPS (TTM)
₹4.49
52W Low
₹36.90
52W High
₹129.35
Dividend Yield
0.00%
Beta
1.15
Price / Book
1.7
Debt / Equity
6.9
Revenue (TTM)
₹83 Cr
Gross Margin
41.44%
Operating Margin
6.30%
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the notice of its 24th Annual General Meeting (AGM) to be held on September 3, 2026, through video conferencing.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its 24th Annual General Meeting (AGM) for the financial year 2025-26, to be held on September 3, 2026, through video conferencing. The meeting will consider the adoption of audited standalone and consolidated financial statements, appointment of a director, and ratification of the remuneration of the cost auditors.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the intimation of its 24th Annual General Meeting to be held on September 3, 2026, through Video Conference (VC)/Other Audio-Visual Means (OAVM).
Brooks Laboratories Ltd
Brooks Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.
Brooks Laboratories Ltd
Brooks Laboratories Ltd announced the closure of its trading window for Designated Persons and their immediate relatives, effective from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. This is a standard compliance measure as per SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct, aimed at preventing insider trading.